Pharmacotherapy-Induced Hepatitis B Reactivation Among Patients With Prior Functional Cure: A Systematic Review.

Rhiannon M BathBrandelyn E DoeringMichael D NailorKellie J Goodlet

Published in: The Annals of pharmacotherapy (2018)

Among patients with prior functional cure of hepatitis B, prophylactic antiviral therapy is recommended with rituximab administration irrespective of indication because of a high risk for HBVr-associated morbidity. Enhanced monitoring alone is reasonable for patients receiving nonrituximab biologics or DAAs.

Keyphrases

high glucose
diabetic rats
diffuse large b cell lymphoma
stem cells
smoking cessation
drug induced
oxidative stress
endothelial cells
hodgkin lymphoma